Loss-of-function mutations in Nav1.7 are associated with congenital insensitivity to pain (CIP) [7-9], while gain-of-function mutations in Nav1.7 are linked to the painful conditions of inherited erythromelalgia and paroxysmal extreme pain disorder (PEPD) [10,11,14,42]. Here, SCN9A is linked to paroxysmal extreme pain disorder.